Ambeed.cn

首页 / / / / Caffeic Acid

咖啡酸 /Caffeic Acid {[allProObj[0].p_purity_real_show]}

货号:A134210 同义名: 3,4-Dihydroxycinnamic Acid

Caffeic Acid是一种羟基肉桂酸,一种天然有机化合物,从东南亚植物Boehmeria siamensis Craib的草本中分离提纯,具有抗氧化、抗肿瘤、抗HIV、胆汁促进、肝向性作用,并且是中性粒细胞弹性蛋白酶的强抑制剂。

Caffeic Acid 化学结构 CAS号:331-39-5
Caffeic Acid 化学结构
CAS号:331-39-5
Caffeic Acid 3D分子结构
CAS号:331-39-5
Caffeic Acid 化学结构 CAS号:331-39-5
Caffeic Acid 3D分子结构 CAS号:331-39-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Caffeic Acid 纯度/质量文件 产品仅供科研

货号:A134210 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >

Caffeic Acid 生物活性

描述 Caffeic acid is an inhibitor of both TRPV1 ion channel and 5-Lipoxygenase (5-LO).
体内研究

Mice treated with Caffeic acid at a dose of 500 mg/kg display a marked reduction in histamine-induced scratching behavior, recording an average of 30.50±10.87 bouts per hour, with a sample size of six. A lower dose of Caffeic acid (100 mg/kg) shows a non-significant reduction in scratching, indicating a possible decreasing trend (49.40±12.35 bouts per hour, n=5). Chloroquine-induced scratching is significantly decreased following pretreatment with 500 mg/kg of Caffeic acid, registering 161.6±31.42 bouts per hour in five subjects[1].

Additionally, Caffeic acid substantially lowers the expression of 5-LO mRNA in a dose-dependent manner in the hippocampus. Compared to the ischemia-reperfusion (I/R) untreated group, 5-LO protein expression significantly diminishes in the I/R-Caffeic acid-treated group, particularly at 50 mg/kg. Relative to the I/R untreated group, the time taken to locate the platform significantly decreases in both low- and high-dose Caffeic acid-treated groups, with the most notable reduction in the I/R-Caffeic acid 50 mg/kg group (P<0.01). In the low-dose Caffeic acid group, cell injury remains pronounced with a pyknosis ratio of 63.6±2.8%, while in the high-dose group, hippocampal neuron pyknosis significantly decreases, showing a pyknosis ratio of 13.3±3.0%[2].

体外研究

Caffeic acid exhibits inhibitory effects on histamine-induced reactions, with its suppressive impact progressively intensifying at concentrations ranging from 0.1 to 1 mM, indicative of a typical dose-dependent response. In HEK293T-TRPV1 cells, a 1 mM pre-incubation with Caffeic acid significantly curtails capsaicin-triggered responses, whereas at lower concentrations, this inhibitory effect on capsaicin-induced reactions is less pronounced. Calcium imaging experiments reveal that Caffeic acid treatment notably reduces activity in histamine-sensitive dorsal root ganglion (DRG) neurons. With a 1 mM Caffeic acid pretreatment, there is a substantial reduction in the proportion of DRG neurons responsive to histamine, decreasing from 12.5% to 2.1%. Additionally, a 1 mM concentration of Caffeic acid effectively obstructs the intracellular calcium increase induced by allylisothiocyanate (AITC) in TRPA1-expressing cells, also preventing AITC-induced TRPA1 activation[1].

Caffeic Acid 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00065715 Common Cold Phase 3 Completed - United States, Wisconsin ... 展开 >> University of Wisconsin-Madison Department of Family Medicine Madison, Wisconsin, United States, 53706-1490 收起 <<
NCT02050334 Healthy Phase 1 Completed - United States, Indiana ... 展开 >> IU Health Neuroscience Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT02050334 - Completed - -

Caffeic Acid 参考文献

[1]Pradhananga S, et al. Caffeic acid exhibits anti-pruritic effects by inhibition of multiple itch transmission pathways in mice. Eur J Pharmacol. 2015 Sep 5;762:313-21.

[2]Liang G, et al. The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats. Behav Brain Funct. 2015 Apr 18;11:18.

Caffeic Acid 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.55mL

1.11mL

0.56mL

27.75mL

5.55mL

2.78mL

55.51mL

11.10mL

5.55mL

Caffeic Acid 技术信息

CAS号331-39-5
分子式C9H8O4
分子量 180.157
别名 3,4-Dihydroxycinnamic Acid
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,Room Temperature

溶解方案

DMSO: 105 mg/mL(582.82 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。